A new kid on the block: The Memory Validity Profile (MVP) in children with neurological conditions.


Journal

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence
ISSN: 1744-4136
Titre abrégé: Child Neuropsychol
Pays: England
ID NLM: 9512515

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 7 6 2018
medline: 9 4 2020
entrez: 7 6 2018
Statut: ppublish

Résumé

Determining the validity of obtained data is an inherent part of a neuropsychological assessment. The purpose of this study was investigate the failure rate of the Memory Validity Profile (MVP) in a large clinical sample of children and adolescents with neurological diagnoses. Data were obtained from 261 consecutive patients (mean age = 12.0, SD = 3.9, range = 5-19) who were referred for a neuropsychological assessment in a tertiary care pediatric hospital and were administered the MVP. In this sample, 4.6% of youth failed the MVP. Mean administration time for the MVP was 7.4 min, although time to complete was not associated with failure rates. Failure rates were held relatively consistent at approximately 5% across age ranges, diagnoses, and psychomotor processing speed abilities. Having very low, below normal, or above normal intellectual abilities did not alter failure rate on the MVP. However, those with intellectual disability (i.e., IQ<70) had a higher fail rate at 12% on MVP Total Score, but only 6% on the MVP Visual portion. Failure rates on the MVP were associated with lower scores on memory tests. This study provides support for using the MVP in children as young as 5 years with neurological diagnoses.

Identifiants

pubmed: 29873604
doi: 10.1080/09297049.2018.1477929
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-572

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Brian L Brooks (BL)

a Neuropsychology Service , Alberta Children's Hospital , Calgary , Canada.
b Departments of Paediatrics, Clinical Neurosciences, and Psychology , University of Calgary , Calgary , Canada.
c Alberta Children's Hospital Research Institute , University of Calgary , Calgary , Canada.

Taryn B Fay-McClymont (TB)

a Neuropsychology Service , Alberta Children's Hospital , Calgary , Canada.
c Alberta Children's Hospital Research Institute , University of Calgary , Calgary , Canada.
d Department of Paediatrics , University of Calgary , Calgary , Canada.

William S MacAllister (WS)

a Neuropsychology Service , Alberta Children's Hospital , Calgary , Canada.
c Alberta Children's Hospital Research Institute , University of Calgary , Calgary , Canada.

Marsha Vasserman (M)

a Neuropsychology Service , Alberta Children's Hospital , Calgary , Canada.
c Alberta Children's Hospital Research Institute , University of Calgary , Calgary , Canada.

Elisabeth M S Sherman (EMS)

e Brain Health Program , Copeman Healthcare Centre , Calgary , Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH